← Evidence map

ArticleJTO clinical and research reports2024

Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial.

Benjamin J Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 39034968